Cargando…
Plasma Brain-Derived Neurotrophic Factor Levels Predict the Clinical Outcome of Depression Treatment in a Naturalistic Study
Remission is the primary goal of treatment for major depressive disorder (MDD). However, some patients do not respond to treatment. The main purpose of this study was to determine whether brain-derived neurotrophic factor (BDNF) levels are correlated with treatment outcomes. In a naturalistic study,...
Autores principales: | Kurita, Masatake, Nishino, Satoshi, Kato, Maiko, Numata, Yukio, Sato, Tadahiro |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3384668/ https://www.ncbi.nlm.nih.gov/pubmed/22761741 http://dx.doi.org/10.1371/journal.pone.0039212 |
Ejemplares similares
-
The noradrenaline metabolite MHPG is a candidate biomarker between the depressive, remission, and manic states in bipolar disorder I: two long-term naturalistic case reports
por: Kurita, Masatake, et al.
Publicado: (2015) -
The Noradrenaline Metabolite MHPG Is a Candidate Biomarker from the Manic to the Remission State in Bipolar Disorder I: A Clinical Naturalistic Study
por: Kurita, Masatake, et al.
Publicado: (2014) -
Yokukansan improves behavioral and psychological symptoms of dementia by suppressing dopaminergic function
por: Takeyoshi, Kenji, et al.
Publicado: (2016) -
Need for medication to complement catecholamines in smoking cessation of hardcore smokers
por: Kawai, Atsuko, et al.
Publicado: (2017) -
Non-24-hour sleep–wake syndrome improved by low-dose valproic acid: a case report
por: Kurita, Masatake, et al.
Publicado: (2016)